Position in TAK
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,139,467
+$678,529 QoQ
Shares Held
115,522
+23.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Boston Partners holds $43,936,854 across 3 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (4.9% of the industry book) .
All Filings in TAK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,139,467 | 115,522 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,460,938 | 93,710 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,726,846 | 117,954 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,634,663 | 105,735 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,964,431 | 132,107 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $914,658 | 69,083 | Shares | Defined | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||